Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference
暂无分享,去创建一个
George Davey Smith | Nicholas J Timpson | Frank Dudbridge | Mark I McCarthy | David M Evans | Colin N A Palmer | Paul W Franks | John Danesh | Catherine John | Louise V Wain | Martin D Tobin | Kaitlin H Wade | Vanessa Y Tan | Laura J Corbin | David A Hughes | Dirk S Paul | Katherine E Tansey | Frances Butcher | Joanna M Howson | Momodou W Jallow | Nathalie Kingston | Cecilia M Lindgren | Michael O'Donavan | Stephen O'Rahilly | Michael J Owen | Ewan R Pearson | Robert A Scott | David A van Heel | John Whittaker | Tim Frayling | Fredrik Karpe | David M. Evans | J. Danesh | L. Wain | M. McCarthy | M. Tobin | M. Owen | K. Tansey | C. Lindgren | T. Frayling | N. Timpson | S. O’Rahilly | J. Whittaker | P. Franks | F. Dudbridge | J. Howson | G. Smith | R. Scott | C. Palmer | D. V. van Heel | F. Karpe | D. Paul | L. Corbin | K. Wade | C. John | V. Tan | E. Pearson | N. Kingston | M. Jallow | D. Hughes | Vanessa Y. Tan | Frances Butcher | Michael O’Donavan | R. Scott | David M. Evans | R. Scott | R. Scott | M. McCarthy | R. Scott
[1] Silja Martikainen,et al. Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes. , 2016, Cell metabolism.
[2] Matthew Hardy,et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource , 2009, Nature Genetics.
[3] Eric J Topol,et al. Genotype-Based Risk and Pharmacogenetic Sampling in Clinical Trials , 2010, Journal of biopharmaceutical statistics.
[4] Jeremy Sugarman,et al. Ethical issues in identifying and recruiting participants for familial genetic research , 2004, American journal of medical genetics. Part A.
[5] Ethan M. Shevach,et al. Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.
[6] B. Wilfond,et al. Research Participants' Perspectives on Genotype-Driven Research Recruitment , 2011, Journal of empirical research on human research ethics : JERHRE.
[7] Bartha Maria Knoppers,et al. Genotype-driven recruitment: a strategy whose time has come? , 2013, BMC Medical Genomics.
[8] C. Palmer,et al. Variants of the peroxisome proliferator-activated receptor γ- and β-adrenergic receptor genes are associated with measures of compensatory eating behaviors in young children , 2007 .
[9] Li Li,et al. The benefits of using genetic information to design prevention trials. , 2013, American journal of human genetics.
[10] Stephanie M. Fullerton,et al. Recommendations for ethical approaches to genotype-driven research recruitment , 2012, Human Genetics.
[11] G. Davey Smith,et al. Mendelian randomization: genetic anchors for causal inference in epidemiological studies , 2014, Human molecular genetics.
[12] J. Meigs. The Genetic Epidemiology of Type 2 Diabetes: Opportunities for Health Translation , 2019, Current Diabetes Reports.
[13] S. Omholt,et al. Phenomics: the next challenge , 2010, Nature Reviews Genetics.
[14] Marcus R Munafò,et al. A recall-by-genotype study of CHRNA5-A3-B4 genotype, cotinine and smoking topography: study protocol , 2014, BMC Medical Genetics.
[15] Francesco Muntoni,et al. Managing clinically significant findings in research: the UK10K example , 2014, European Journal of Human Genetics.
[16] Amy L McGuire,et al. Don't throw the baby out with the bathwater: enabling a bottom-up approach in genome-wide association studies. , 2008, Genome research.
[17] M. Pangalos,et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework , 2014, Nature Reviews Drug Discovery.
[18] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[19] A. Hingorani,et al. Nature's randomised trials , 2005, The Lancet.
[20] R Garrett Morgan,et al. Network Mendelian Randomization Study Design to Assess Factors Mediating the Causal Link Between Telomere Length and Heart Disease. , 2017, Circulation research.
[21] Steven A Goldstein,et al. Variable Bone Fragility Associated With an Amish COL1A2 Variant and a Knock-in Mouse Model , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] D. Lawlor,et al. Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults , 2017, bioRxiv.
[23] Asher Mullard,et al. Calls grow to tap the gold mine of human genetic knockouts , 2017, Nature Reviews Drug Discovery.
[24] Paul C. Fletcher,et al. Divergent effects of central melanocortin signalling on fat and sucrose preference in humans , 2016, Nature Communications.
[25] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[26] Alan R. Shuldiner,et al. The ABCG8 G574R Variant, Serum Plant Sterol Levels, and Cardiovascular Disease Risk in the Old Order Amish , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[27] Tony R. Merriman,et al. Insight into rheumatological cause and effect through the use of Mendelian randomization , 2016, Nature Reviews Rheumatology.
[28] David B Goldstein,et al. Ethical challenges in genotype-driven research recruitment. , 2010, Genome research.
[29] Mark Atkinson,et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes , 2007, Nature Genetics.
[30] Peter Kraft,et al. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. , 2015, American journal of human genetics.
[31] Colin N A Palmer,et al. Tailored second-line therapy in asthmatic children with the Arg(16) genotype. , 2013, Clinical science.
[32] Stephen Burgess,et al. Mendelian randomization: where are we now and where are we going? , 2015, International journal of epidemiology.
[33] Alan R. Shuldiner,et al. Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish , 2014, Diabetologia.
[34] M. McCarthy,et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.
[35] Adrian P Mander,et al. Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial , 2016, PLoS medicine.
[36] Hanieh Yaghootkar,et al. Functional characterisation of ADIPOQ variants using individuals recruited by genotype , 2016, Molecular and Cellular Endocrinology.
[37] Nicholas J. Timpson,et al. Genetics, sleep and memory: a recall-by-genotype study of ZNF804A variants and sleep neurophysiology , 2015, BMC Medical Genetics.
[38] Daniel G. MacArthur,et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity , 2017, Nature.
[39] Sarah E. Medland,et al. Mining the Human Phenome Using Allelic Scores That Index Biological Intermediates , 2013, PLoS genetics.
[40] R. Collins. What makes UK Biobank special? , 2012, The Lancet.
[41] Mattias Ohlsson,et al. Statistical power considerations in genotype-based recall randomized controlled trials , 2016, Scientific Reports.
[42] P. Visscher,et al. Common SNPs explain a large proportion of heritability for human height , 2011 .
[43] James T. Elder,et al. Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study , 2016, PLoS medicine.
[44] Peter M Visscher,et al. Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. , 2009, Human molecular genetics.
[45] George Davey Smith,et al. Using multiple genetic variants as instrumental variables for modifiable risk factors , 2012, Statistical methods in medical research.
[46] Nicholas Timpson,et al. The ethics conundrum in Recall by Genotype (RbG) research: Perspectives from birth cohort participants , 2017, bioRxiv.
[47] D. Altshuler,et al. Validating therapeutic targets through human genetics , 2013, Nature Reviews Drug Discovery.
[48] S. Schulz,et al. ADORA2A genotype modulates interoceptive and exteroceptive processing in a fronto-insular network , 2016, European Neuropsychopharmacology.
[49] Pak Chung Sham,et al. GWASdb: a database for human genetic variants identified by genome-wide association studies , 2011, Nucleic Acids Res..
[50] Jeffrey R O'Connell,et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. , 2014, The New England journal of medicine.
[51] B. Wilfond,et al. Disclosing Individual Genetic Results to Research Participants , 2006, The American journal of bioethics : AJOB.
[52] Christopher E Brightling,et al. Cohort Profile Cohort Profile : Extended Cohort for E-health , Environment and DNA ( EXCEED ) , 2019 .
[53] F. Karpe,et al. The in vivo effects of the Pro12Ala PPARγ2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank , 2005, Diabetologia.
[54] Linda S. Wicker,et al. Type 1 Diabetes-Associated IL2RA Variation Lowers IL-2 Signaling and Contributes to Diminished CD4+CD25+ Regulatory T Cell Function , 2012, The Journal of Immunology.
[55] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[56] Mulin Jun Li,et al. Nature Genetics Advance Online Publication a N a Ly S I S the Support of Human Genetic Evidence for Approved Drug Indications , 2022 .
[57] P. Visscher,et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.
[58] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[59] R. Simon,et al. On the efficiency of targeted clinical trials , 2005, Statistics in medicine.